Sonoda Hiromichi, Hamada Junichi, Shimomura Katsumi, Itokawa Yoshiki, Ikeda Jun, Taniguchi Fumihiro, Ueshima Yasuo, Takashina Kenichiro, Lee Choljee, Shioaki Yasuhiro
Dept. of Surgery, Japanese Red Cross Kyoto Daiichi Hospital, Japan.
Gan To Kagaku Ryoho. 2011 Jul;38(7):1179-81.
A 70-year-old woman with unresectable advanced gastric cancer accompanied by peritoneal dissemination underwent jejunostomy, and was treated with S-1 and low-dose CDDP. One course consisted of S-1 (80 mg/day) via an intestinal fistula tube from days 1 to 14. This was followed by 7 days rest, and CDDP (20 mg/day) was administered by 1-hour continuous intravenous infusion on day 1 and 8. She continued to receive this chemotherapy for a total of 14 courses, followed by 3 courses of a weekly paclitaxel regimen. She died 14 months after surgery. All chemotherapy had been conducted in an outpatient setting. We concluded that the administration of S-1, combined with low-dose CDDP (div) through a jejunostomy, can improve the quality of life (QOL) of a patient who has unresectable advanced gastric and is incapable of oral intake. We report this rare case with a review of the literature.
一名70岁患有无法切除的晚期胃癌并伴有腹膜播散的女性接受了空肠造口术,并接受S-1和低剂量顺铂治疗。一个疗程包括从第1天到第14天通过肠瘘管给予S-1(80毫克/天)。随后休息7天,在第1天和第8天通过1小时持续静脉输注给予顺铂(20毫克/天)。她总共接受了14个疗程的这种化疗,随后是3个疗程的每周紫杉醇方案。她在手术后14个月死亡。所有化疗均在门诊进行。我们得出结论,通过空肠造口术给予S-1联合低剂量顺铂(分剂量)可以改善无法切除的晚期胃癌且无法经口摄入的患者的生活质量(QOL)。我们报告这例罕见病例并复习文献。